Regulatory mechanisms of galectin-9 and eotaxin-3 synthesis in epidermal keratinocytes: Possible involvement of galectin-9 in dermal eosinophilia of Th1-polarized skin inflammation

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 61, Issue 12, 2006, Pages 1385-1391

  Igawa, K ^a   Satoh, T ^a   Hirashima, M ^b   Yokozeki, H ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Eosinophils; Eotaxin; Eotaxin 3; Galectin 9; Psoriasis

Indexed keywords

CHEMOATTRACTANT; ECALECTIN; EOTAXIN; EOTAXIN 2; EOTAXIN 3; GALECTIN; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL POLARITY; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIA; EPIDERMIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PSORIASIS VULGARIS; REGULATORY MECHANISM; SKIN FIBROBLAST; SKIN INFLAMMATION; STIMULUS RESPONSE; TH1 CELL;

ANIMALS; CELLS, CULTURED; CHEMOKINES, CC; CHEMOTACTIC FACTORS; DERMATITIS; EOSINOPHILIA; EPIDERMIS; FIBROBLASTS; GALECTINS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; KERATINOCYTES; RABBITS; TH1 CELLS; TH2 CELLS;

EID: 33750515260     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01130.x     Document Type: Article

References (28)

1. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schroeder JM. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998;160:60-68.
2. Hoeck J, Woisetschlager M. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-α-induced fibroblasts. J Immunol 2001;166:4507-4515.
3. Dulkys Y, Schramm G, Kimmig D, Knoß S, Weyergraf A, Kapp A et al. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils. J Invest Dermatol 2001;116:498-505.
4. Hoeck J, Woisetschlager M. Activation of eotaxin-3/CCL26 gene expression in human dermal fibroblasts is mediated by STAT6. J Immunol 2001;167:3216-3222.
5. Hein H, Schlueter C, Kulke R, Christophers E, Schroeder J-M, Bartels J. Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochem Biophys Res Commun 1997;237:537-542.
6. Lilly CM, Nakamura H, Kesselman H, Nagler-Anderson C, Asano K, Garcia-Zepeda EA et al. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest 1997;99:1767-1773.
7. Fujisawa T, Kato Y, Atsuta J, Terada A, Iguchi K, Kamiya H et al. Chemokine production by the BEAS-2B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by TH2- and TH1-derived cytokines. J Allergy Clin Immunol 2000;105:126-133.
8. Kobayashi I, Yamamoto S, Nishi N, Tsuji K, Imayoshi M, Inada S et al. Regulatory mechanisms of Th2 cytokine-induced eotaxin-3 production in bronchial epithelial cells: possible role of interleukin-4 receptor and nuclear factor-kappa B. Ann Allergy Asthma Immunol 2004;93:390-397.
9. Komiya A, Nagase H, Yamada H, Sekiya T, Yamaguchi M, Sano Y et al. Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells. Cell Immunol 2003;225:91-100.
10. Dajotoy T, Andersson P, Bjartell A, Loefdahl C-G, Trapper H, Egesten A. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-γ. J Leukoc Biol 2004;76:685-691.
11. Jeziorska M, Haboubi N, Schofield P, Wooley DE. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique. J Pathol 2001;194:484-492.
12. Camoglio L, Te Velde AA, Tiggers AJ, Das PK, Van Deventer SJ. Altered expression of interferon-γ and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis 1998;4:285-290.
13. Asakura H, Kashio Y, Nakamura K, Seki M, Dai S, Shirato Y et al. Selective eosinophil adhesion to fibroblasts via IFN-γ-induced galectin-9. J Immunol 2002;169:5912-5918.
14. Sato M, Nishi N, Shoji H, Seki M, Hashidate T, Hirabayashi J et al. Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity. Glycobiology 2002;12:191-197.
15. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 1998;273:16976-16984.
16. Imaizumi T, Kumagai M, Sasaki N, Kurotaki H, Mori F, Seki M et al. Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol 2002;72:486-491.
17. Yang XY, Jiang H, Hartmann WK, Mitra G, Soman G. Development of a quantitative antigen-specific cell-based ELISA for the 7G7/B6 monoclonal antibody directed toward IL-2Ralpha. J Immunol Methods 2003;277:87-100.
18. Jean-Baptiste S, O'Toole EA, Chen M, Guitart J, Paller A, Chan LS. Expression of eotaxin, an eosinophil-selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti. Clin Exp Immunol 2002;127:470-478.
19. Trautmann A, Akdis M, Kleemann D, Altznauer F, Simon U, Graeve T et al. T cell-mediated Fas-induced keratinocytes apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 2000;106:25-35.
20. Konur A, Schulz U, Eissner G, Andreesen R, Holler E. Interferon (IFN)-γ is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-γ and tumor necrosis factor-α production. Br J Dermatol 2005;152:1134-1142.
21. Kagami S, Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Nakamura K et al. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxhin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Clin Exp Immunol 2003;134:309-313.
22. Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994;102:145-149.
23. Lundin A, Fredens K, Michaelsson G, Venge P. The eosinophil granulocyte in psoriasis. Br J Dermatol 1990;122:181-193.
24. Fukuoka M, Ogino Y, Sato H, Ohta T, Komoriya K, Nishioka K et al. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol 1998;138:63-70.
25. Sticherling M, Kupper M, Koltrowitz F, Bornscheuer E, Kulke R, Klinger M et al. Detection of chemokine RANTES in cytokine-stimulated human dermal fibroblasts. J Invest Dermatol 1995;105:585-591.
26. Li J, Ireland GW, Farthing PM, Thornhill MH. Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. J Invest Dermatol 1996;106:661-666.
27. Jinquan T, Jing C, Jacobi HH, Reimert CM, Millner A, Quan S et al. CXCR3 expression and activation of eosinophils: role of IFN-γ-inducible protein-10 and monokine induced by IFN-γ. J Immunol 2000;165:1548-1556.
28. Saita N, Goto E, Yamamoto T, Cho I, Tsumori K, Kohrogi H et al. Association of galectin-9 with eosinophil apoptosis. Int Arch Allergy Immunol 2002;128:42-50.